Smoking and Eye Pathologies. A Systemic Review. Part II. Retina Diseases, Uveitis, Optic Neuropathies, Thyroid-Associated Orbitopathy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|23|4|639-654

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.23, Iss.4, 2017-03, pp. : 639-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Updated Review on the Most Common Agents Causing Toxic Optic Neuropathies

By  

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 586-595

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Treatment for Severe Thyroid-associated Ophthalmopathy with Tocilizumab

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 6, 2018-11 ,pp. : 665-667

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic and phenotypic variability of optic neuropathies

By Neuhann Teresa   Rautenstrauss Bernd  

Expert Review of Neurotherapeutics, Vol. 13, Iss. 4, 2013-04 ,pp. : 357-367

Informa Healthcare

Access to resources Recommend Favorite

Anti-VEGF Drugs in Eye Diseases: Local Therapy with Potential Systemic Effects

By  

Current Pharmaceutical Design, Vol. 21, Iss. 24, 2015-01 ,pp. : 3548-3556

Bentham Science Publishers

Access to resources Recommend Favorite

Periodontal Disease and Potential Association with Systemic Diseases and Conditions (Mini-review)

By  

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-08 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite